NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, reported its financial and operational results for the third ...

Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a ...

NervGen Pharma (TSE:NGEN) has released an update. NervGen Pharma, a clinical-stage biotech company, is set to present at the Stifel 2024 ...

The race moves to the November general election for the four-year term of District 5 Cape Coral City Council representative, featuring Joseph Kilraine and Charlie Pease who made it through the ...

According to the article, Kotak Securities and Citigroup will most likely serve as bankers for the Torrent Pharma transaction. Torrent Pharma shares closed Tuesday’s session at ₹3,207 on the ...

Strides Pharma reported Q2 FY25 net profit of ₹93 Crore, marking a recovery from a ₹131 Crore loss in the same quarter last year. Revenue for Q2 FY25 reached ₹1,201 Crore, reflecting a 20.2% ...

Mark Cuban says he gave up majority ownership of the Dallas Mavericks and his seat on the hit TV show Shark Tank to focus on lowering pharmaceutical drugs prices for Americans.(Shafkat Anowar ...

Target enrollment in the chronic cohort close to completionVancouver, British Columbia--(Newsfile Corp. - September 30, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage ...

NAFDAC strike worsens pharma manufacturers’ struggles 25th October 2024 Director General, National Agency for Food and Drug Administration and Control, Prof. Mojisola Adeyeye.

ABUJA – THE Director General, African Centre for Supply Chain, ACSC, Dr Obiora Madu, Thursday, declared that supply chain services remain catalyst to the country’s pharma sector and others.

Featured here, the Balance Sheet for NervGen Pharma Corp, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ...

According to the forecasts, Sun Pharma's EBITDA may scale up to 27.5 percent in the September quarter, as against 26.1 percent in the year ago period. Earnings forecasts by analysts polled by ...